Researchers unveiled a novel therapy for diabetic wound healing. This research highlights the use of exosomal miR-4645-5p from hypoxic bone marrow mesenchymal stem cells (BMSCs) to significantly enhance wound healing by promoting keratinocyte autophagy.
Evox Therapeutics teams with New York medical school to co-develop AAV vectors – Pharmaceutical Technology
Exosomes are quickly taken up by cells and have rapid clearance from circulation, leading to an efficient delivery of therapeutic payloads to organs of interest.